The Multi-Modality Approach to Image-Guided Biopsy
Modern breast biopsy is rarely a "blind" procedure; rather, it is guided by the imaging modality that best visualizes the suspicious lesion. As of 2026, clinical guidelines specify the following primary guidance methods:
Ultrasound-Guided Biopsy: This is the preferred method for masses that are easily visible via ultrasound. The patient lies comfortably on their back or side while a radiologist uses a high-frequency probe to track the needle's path in real-time, ensuring it enters the exact center of the lesion.
Stereotactic (Mammography-Guided) Biopsy: This method is essential for detecting microcalcifications or architectural distortions that are only visible on a mammogram. Advanced 2026 systems often utilize 3D Tomosynthesis (Digital Breast Tomosynthesis or DBT) to provide a clearer, three-dimensional view, which reduces the number of samples needed and improves accuracy in dense breast tissue.
MRI-Guided Biopsy: Reserved for suspicious areas seen only on an MRI. Because the MRI environment uses strong magnets, all biopsy equipment—from the needle to the vacuum probe—must be specially designed non-metallic components.